BPC-157 TB-500 Blend Dosage Canada for Labrum

7 min read

The BPC-157 and TB-500 blend dosage for shoulder labrum tear recovery in Canada typically ranges from 250 mcg to 500 mcg of each peptide once daily, injected subcutaneously near the injury. Most researchers use this combined dose for 4 to 8 weeks to support tendon and cartilage healing. This article covers the exact protocol, reconstitution steps, and where to source research-grade peptides in Canada.

Why Combine BPC-157 and TB-500 for a Labrum Tear

A shoulder labrum tear is a tear of the fibrocartilage rim around the shoulder socket. It often causes pain, instability, and reduced range of motion. Surgery is common, but recovery can be slow. BPC-157 and TB-500 are research peptides studied for their tissue repair properties. BPC-157 promotes angiogenesis and fibroblast migration. TB-500, a fragment of thymosin beta-4, regulates actin and cell migration. Together they may accelerate healing of connective tissue.

For researchers in Canada, sourcing these peptides requires careful attention to purity and legal status. Both are sold for laboratory use only. The blend is not approved by Health Canada for human use. However, many Canadian researchers study these compounds in animal models of tendon and ligament injury. The combination is popular because the mechanisms are complementary. BPC-157 works locally on the injury site. TB-500 works systemically to reduce inflammation and promote cell migration.

BPC-157 TB-500 Blend Dosage Canada: Standard Protocol

The most common dosage for a labrum tear is 250 mcg of BPC-157 plus 250 mcg of TB-500 once daily. Some protocols use 500 mcg of each once daily for the first two weeks, then reduce to 250 mcg daily. The injection is given subcutaneously, as close to the shoulder as possible without hitting the joint. Rotate injection sites to avoid irritation.

Cycle length is typically 4 to 8 weeks. A 4-week cycle may be enough for minor tears. A full 8-week cycle is better for chronic or post-surgical labrum injuries. After 8 weeks, a 2-week break is recommended before considering another cycle. Do not exceed 8 weeks continuously without a break.

For researchers who prefer a single injection, many suppliers offer a pre-mixed BPC-157 and TB-500 blend. The typical blend ratio is 1:1, such as 5 mg BPC-157 and 5 mg TB-500 in one vial. Reconstitute with 2 mL of bacteriostatic water. Then each 0.1 mL contains 250 mcg of each peptide. This simplifies dosing and reduces injection frequency.

How to Reconstitute the Blend for Labrum Research

Reconstitution is critical for accurate dosing. Use bacteriostatic water, not sterile water, to prevent bacterial growth. For a 5 mg/5 mg blend vial, add 2 mL of bacteriostatic water. Gently swirl, do not shake. The solution should be clear. Store reconstituted peptides in the refrigerator at 2 to 8 degrees Celsius. Use within 30 days for best stability.

To draw a 250 mcg dose of each peptide, use an insulin syringe with 0.3 mL or 0.5 mL capacity. Draw 0.1 mL, which equals 250 mcg of BPC-157 and 250 mcg of TB-500. Inject subcutaneously into the fatty tissue over the deltoid or upper arm. Avoid injecting directly into the joint or muscle. Rotate sites daily.

BPC-157 Shoulder Labrum Tear: What the Research Shows

BPC-157 has been studied in rodent models of tendon and ligament injury. It accelerates healing of transected Achilles tendons and medial collateral ligaments. It also promotes healing of muscle and bone. For labrum tears, the mechanism is similar. BPC-157 increases growth factor expression and blood vessel formation. This may improve repair of the fibrocartilage rim.

TB-500 has been studied for dermal and corneal wound healing. It also reduces inflammation and promotes cell migration. In animal models of cardiac injury, TB-500 improved function. For shoulder labrum tears, TB-500 may reduce inflammation and support collagen deposition. The combination of BPC-157 and TB-500 is not directly studied in human labrum tears. But the individual mechanisms support the rationale.

One study on BPC-157 in rats with medial collateral ligament transection showed faster healing and better biomechanical properties. Another study on TB-500 in mice with full-thickness skin wounds showed accelerated closure. These findings are extrapolated to labrum tears. Researchers in Canada often cite these studies when designing protocols.

Peptides for Labrum Recovery: Comparing Options

Besides BPC-157 and TB-500, other peptides are sometimes used for labrum recovery. These include CJC-1295, Ipamorelin, and GHRP-6. These growth hormone secretagogues increase IGF-1, which supports tissue repair. However, they do not act directly on the injury site. BPC-157 and TB-500 are more targeted for connective tissue.

For a labrum tear, the BPC-157 and TB-500 blend is often preferred because it addresses both local and systemic healing. The dosage is lower than using each peptide alone. This reduces cost and injection burden. Some researchers add a growth hormone peptide for enhanced recovery. But the core blend remains BPC-157 and TB-500.

If you are comparing BPC-157 and TB-500 individually, see our article on BPC-157 vs TB-500 for recovery. For a detailed guide on the 5 mg blend dosage, read the 5 mg BPC-157 and TB-500 blend dosage guide.

Where to Buy BPC-157 TB-500 Blend in Canada

Canadian researchers can buy BPC-157 and TB-500 blends from online peptide suppliers. Prices vary. A 5 mg/5 mg blend vial typically costs between $60 and $120 CAD. Some suppliers offer kits with bacteriostatic water and syringes. Always request a certificate of analysis for purity, usually above 98%.

When buying in Canada, check shipping times and customs policies. Peptides for research are legal to import for laboratory use. But some suppliers ship from overseas, which may delay delivery. Look for Canadian domestic suppliers to avoid customs issues. For a specific product, see our guide on buying BPC-157 5 mg in Canada.

Do not buy from unverified sources. Counterfeit peptides are common. Always verify the supplier's reputation and third-party testing. The blend should be lyophilized powder, not liquid. Liquid peptides degrade faster and are often fake.

Potential Side Effects and Safety Notes

BPC-157 and TB-500 are generally well tolerated in animal studies. Reported side effects are mild. These include injection site redness, itching, or temporary fatigue. Some researchers report headaches or dizziness. No serious adverse events have been published in human case reports. However, long-term safety data are lacking.

Because these peptides are not approved for human use, researchers must follow ethical guidelines. Do not use on humans. For more on risks, see our article on BPC-157 and TB-500 side effects.

Pregnant or nursing animals should not be used. Avoid if there is a history of cancer, as angiogenesis promotion could theoretically accelerate tumor growth. Always consult a veterinarian or institutional review board before starting any peptide study.

Sample Protocol for a Shoulder Labrum Tear Study

Here is a common protocol used by Canadian researchers for a labrum tear model:

  • Week 1-2: 500 mcg BPC-157 + 500 mcg TB-500 once daily, subcutaneous near shoulder.
  • Week 3-8: 250 mcg BPC-157 + 250 mcg TB-500 once daily.
  • Inject at the same time each day, preferably morning.
  • Monitor for injection site reactions and overall activity levels.
  • After 8 weeks, stop for 2 weeks before reassessing.

This protocol is based on extrapolation from animal studies. It is not a clinical recommendation. Adjust based on the animal's weight and response. Smaller animals may need lower doses. Larger animals may need higher doses. Always start low and titrate up if needed.

Frequently Asked Questions About the Blend Dosage

Can I inject the blend directly into the shoulder joint?

No. Intra-articular injection is not recommended for research. Subcutaneous injection near the joint is safer and still delivers the peptide to the area. Direct joint injection risks infection and cartilage damage.

How long does it take to see results in a labrum tear?

In animal models, improvements are often seen within 2 to 4 weeks. Full healing may take 8 weeks or more. The labrum has poor blood supply, so healing is slow. The blend may accelerate this process, but patience is required.

Can I use the blend after labrum surgery?

Some researchers study the blend post-surgery to enhance recovery. The dosage is the same. However, avoid injecting near the surgical site until the incision has healed. Wait at least 1 week post-op before starting.

Is the BPC-157 TB-500 blend legal in Canada?

Yes, for research purposes. The peptides are not scheduled drugs. But they are not approved for human consumption. Selling them for human use is illegal. Always purchase from a reputable supplier that sells for research only.

Key Takeaways for Canadian Researchers

The BPC-157 and TB-500 blend dosage for shoulder labrum tear recovery in Canada is 250 to 500 mcg of each peptide once daily for 4 to 8 weeks. Reconstitute with bacteriostatic water and inject subcutaneously near the shoulder. This combination targets both local and systemic healing pathways. Always source from a verified Canadian supplier and follow ethical research guidelines.

For a deeper comparison of these two peptides, read our article on BPC-157 vs TB-500 for recovery. If you are also interested in BPC-157 for other tissue repairs, see our guide on BPC-157 dosage for tissue repair.

Share This Article